Preclinical Studies Identify Non-Apoptotic Low-Level Caspase-3 as Therapeutic Target in Pemphigus Vulgaris

• Camille Luyet,

  Affiliations Molecular Dermatology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland

  ⨯
• Katja Schulze,

  Current address: F. Hoffmann-La Roche Ltd., Basel, Switzerland

  Affiliations Molecular Dermatology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland

  ⨯
• Beyza S. Sayar,

  Affiliations Molecular Dermatology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland

  ⨯
• Denise Howald,

  Affiliations Molecular Dermatology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland

  ⨯
• Eliane J. Müller,

  Affiliations Molecular Dermatology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland, Department of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland

  ⨯
• Arnaud Galichet

  * E-mail: arnaud.galichet@vetsuisse.unibe.ch

  Affiliations Molecular Dermatology, Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland, DermFocus, Vetsuisse Faculty, University of Bern, Bern, Switzerland

  ⨯